Cargando…
Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study
BACKGROUND: Multiple myeloma (MM) is associated with a high risk of thrombosis, particularly during the first months of treatment including immunomodulatory drugs (IMiDs). There is no consensus on prevention of thromboembolic risk in patients with de novo MM, and identification of patients requiring...
Autores principales: | Chalayer, Emilie, Tardy‐Poncet, Brigitte, Karlin, Lionel, Chapelle, Céline, Montmartin, Aurélie, Piot, Michèle, Guyotat, Denis, Collet, Philippe, Lecompte, Thomas, Tardy, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332829/ https://www.ncbi.nlm.nih.gov/pubmed/30656281 http://dx.doi.org/10.1002/rth2.12161 |
Ejemplares similares
-
External validation of the MidiCAT variant of thrombography: Comparison with calibrated automated thrombography and study of the centrifugation scheme
por: Charles, Sebastien, et al.
Publicado: (2022) -
PHILEOS (haemoPHILia and ostEoporOSis) Study: protocol of a multicentre prospective case–control study
por: Tardy‐Poncet, Brigitte, et al.
Publicado: (2021) -
Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2021) -
The intestinal microbiome potentially affects thrombin generation in human subjects
por: Mohammed, Yassene, et al.
Publicado: (2019) -
Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
por: Blondon, Marc, et al.
Publicado: (2022)